DOTAP:DOPC:Chol:DSPE-N-DBCO(5:64:30:1molar ratio)-based Fluoroliposome DiD-DBCO

This DOTAP:DOPC:Chol:DSPE-DBCO-based fluoro-liposome formulation encapsulating DiD provides a robust platform for various biomedical applications, especially in drug delivery and imaging.
The encapsulation of DiD allows researchers to visualize the distribution and localization of the liposomes in biological systems, which can be critical for tracking drug delivery and understanding biodistribution.
The reactive DSPE-DBCO allows for post-formation conjugation with targeting ligands (e.g., antibodies or peptides), potentially directing the liposomes to specific cell types or tissues.
The cationic nature of DOTAP can be beneficial in delivering nucleic acids, such as plasmid DNA or RNA, enhancing transfection efficiency.

msds of dotap-dopc-chol-dspe-dbco-5-64-30-1molar-ratio-based-fluoroliposome-did-dbco